CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $201,787
- in 1 filing
Net −$201,787. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-12 | KOCH KEVIN President and CEO | Grant or award · Restricted Stock Units | +87,500 | 87,500 | ||
| 2025-08-12 | KOCH KEVIN President and CEO | Grant or award · Stock Option (Right to Buy) | +525,000 | 525,000 | ||
| 2025-08-12 | Donovan Joanne M. CMO | Option exercise | +5,781 | 28,223 | ||
| 2025-08-12 | Donovan Joanne M. CMO | Sale | −2,862 | $13.39 | $38K | 25,361 |
| 2025-08-12 | Donovan Joanne M. CMO | Option exercise · Restricted Stock Units | −5,781 | 17,344 | ||
| 2025-08-12 | Donovan Joanne M. CMO | Grant or award · Restricted Stock Units | +28,125 | 28,125 | ||
| 2025-08-12 | Donovan Joanne M. CMO | Grant or award · Stock Option (Right to Buy) | +168,750 | 168,750 | ||
| 2025-07-01 | Fox Jonathan C Director | Grant or award | +858 | 12,274 | ||
| 2025-06-16 | Brege Laura Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-06-16 | Edris Badreddin Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-06-16 | Fox Jonathan C Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-06-16 | Morris Arlene Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-06-16 | ROOT JONATHAN D Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-06-16 | Thompson Peter A. Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-05-02 | Russell Alan J Chief Scientific Officer | Sale | −1,551 | $16.45 | $26K | 18,521 |
| 2025-05-02 | MOORE JOHN R General Counsel | Sale | −1,930 | $16.45 | $32K | 6,531 |
| 2025-05-02 | KOCH KEVIN President and CEO | Sale | −4,276 | $16.45 | $70K | 20,619 |
| 2025-05-02 | Donovan Joanne M. CMO | Sale | −5,187 | $16.45 | $85K | 21,588 |
| 2025-05-02 | Derakhshan Behrad Chief Business Officer | Sale | −1,691 | $16.45 | $28K | 20,355 |
| 2025-05-02 | Carruthers R Michael Chief Financial Officer | Sale | −1,314 | $16.45 | $22K | 81,014 |
Page 8 of 26 · 509 trades